• Source: GRL-0617

GRL-0617 is a drug which is one of the first compounds discovered that acts as a selective small-molecule inhibitor of the protease enzyme papain-like protease (PLpro) found in some human pathogenic viruses, including the coronavirus SARS-CoV-2. It has been shown to inhibit viral replication in silico and in vitro.




See also


3CLpro-1
Ebselen
GC376




References

Kata Kunci Pencarian:

• GRL-0617
• 3C-like protease
• GC376
• 3CLpro-1
• Lufotrelvir